Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 46,857 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the completion of the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Amit Gupta also recently made the following trade(s):

  • On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The shares were sold at an average price of $3.92, for a total value of $59,427.20.
  • On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.

Cardlytics Stock Performance

Cardlytics stock traded down $0.25 during midday trading on Wednesday, hitting $3.12. 795,583 shares of the company’s stock were exchanged, compared to its average volume of 892,856. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $158.56 million, a price-to-earnings ratio of -0.51 and a beta of 1.54. Cardlytics, Inc. has a 12-month low of $2.76 and a 12-month high of $20.52. The firm’s 50 day simple moving average is $3.47 and its 200 day simple moving average is $3.73.

Hedge Funds Weigh In On Cardlytics

Hedge funds and other institutional investors have recently made changes to their positions in the stock. SG Americas Securities LLC acquired a new position in shares of Cardlytics during the third quarter worth about $45,000. Creative Planning grew its position in shares of Cardlytics by 35.4% in the third quarter. Creative Planning now owns 29,537 shares of the company’s stock valued at $95,000 after purchasing an additional 7,721 shares during the period. Acorn Financial Advisory Services Inc. ADV increased its position in Cardlytics by 40.5% during the third quarter. Acorn Financial Advisory Services Inc. ADV now owns 164,409 shares of the company’s stock worth $526,000 after purchasing an additional 47,358 shares during the last quarter. GSA Capital Partners LLP lifted its stake in shares of Cardlytics by 1,273.2% in the 3rd quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock valued at $1,223,000 after purchasing an additional 354,474 shares in the last quarter. Finally, Brooktree Capital Management lifted its holdings in shares of Cardlytics by 24.7% during the 3rd quarter. Brooktree Capital Management now owns 167,642 shares of the company’s stock valued at $536,000 after acquiring an additional 33,169 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CDLX. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Friday, January 17th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Cardlytics has a consensus rating of “Hold” and an average target price of $6.92.

Get Our Latest Research Report on Cardlytics

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.